Don’t forget AGY is run by a board of directors and one of the members of the board just pulled off a stunning deal with, yep the Japanese, for another of his companies.
I wouldn’t worry too much about AGY. They will get their finance, as JZ has intimated there is now enuf OT/strategic support to justify a move to stage 3 in whatever form it takes.
As we have discussed before AGY is now at the behest of the OTers and their testing and all parties MUST get this right.
IF the OTer is involved in the finance then ultimately the two deals, namely the OT and the finance, will be connected. It may not happen in the OT altho there may be an initial mou, but we may still need to see both developments sorted before an annmnt can be made and this makes it all the more complex as there will be legals and red tape involved.
Patience required here for a little bit more time imho.
Gr.
- Forums
- ASX - By Stock
- AGY
- General Comments & Banter
General Comments & Banter, page-11581
-
-
- There are more pages in this discussion • 3,318 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.95M |
Open | High | Low | Value | Volume |
3.7¢ | 3.7¢ | 3.5¢ | $116.1K | 3.177M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 3422978 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 117789 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 3422978 | 0.035 |
17 | 2085124 | 0.034 |
12 | 1403935 | 0.033 |
4 | 715000 | 0.032 |
3 | 504333 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 117789 | 2 |
0.037 | 1603662 | 11 |
0.038 | 1521677 | 7 |
0.039 | 1495481 | 8 |
0.040 | 720475 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online